Fig. 1From: The effects of reimbursement reform of antidiabetic medicines from the patients’ perspective – a survey among patients with type 2 diabetes in FinlandRecipients of reimbursement and expenditure on blood glucose lowering medicines, excluding insulins (ATC-code A10B) in Finland [6]Back to article page